Alzheimer’s Drug May Benefit Some Patients, New Data Shows
The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.
- Leaders in Congress Say They Will Act to Prevent Rail Strike
- China Launches Astronauts to Tiangong Space Station: Video and Updates
